Health Care Mutual Funds

Publication
Article
Psychiatric TimesPsychiatric Times Vol 14 No 6
Volume 14
Issue 6

One type of investment that psychiatrists might find especially intriguing are health care mutual funds-specialized portfolios that invest in medical companies ranging from pharmaceutical manufacturers to biotechnology firms to health maintenance organizations. Although these industry-specific funds should not be held in isolation, they can provide solid long-term growth potential to a well-diversified portfolio. Here's key information on five top funds:

One type of investment that psychiatrists might find especially intriguing are health care mutual funds-specialized portfolios that invest in medical companies ranging from pharmaceutical manufacturers to biotechnology firms to health maintenance organizations. Although these industry-specific funds should not be held in isolation, they can provide solid long-term growth potential to a well-diversified portfolio. Here's key information on five top funds:

  • Fund Name
  • Sales Charge/Load
  • Phone
  • Average Annual Return*
  • MinimumEaton Vance Traditional Worldwide Health Sciences

4.7%
800-225-6265
+17.98%
$1,000

  • Vanguard Specialized Health Care

None
800-662-7447
+17.81%
$3,000

  • Fidelity Select Health Care
    3%
    800-544-8888
    +13.64 percent
    $2,500Putnam Health Sciences

5.75%
800-225-1581
+13.50 percent
$500

  • T. Rowe Price Health Sciences

None
800-638-5660
N.A.**
$2,500

Notes: Performance results are average annualized figures for the five years through Jan. 31, 1997, as provided by Morningstar Inc. of Chicago. The T. Rowe Price fund debuted in December 1995.

Back to Investing: It's All About Making Your Money Work

Related Videos
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Video 8 - "Treatment Augmentation in a Patient with Narcolepsy and ADHD"
Video 7 - "Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms"
Video 6 - "Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks"
Video 5 - "Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations"
Video 2 - "Narcolepsy Evaluation, Management, and Treatment Considerations"
Video 2 - "Diagnostic Practices for Narcolepsy"
© 2024 MJH Life Sciences

All rights reserved.